Clinical Trial Update: Role of Sub-Conjunctival Bevacizumab in Post Pterygium Excision Management [Phase 4]

View source ↗

Summary

This clinical trial update discusses a Phase 4 study evaluating sub-conjunctival bevacizumab for management after pterygium excision, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pterygium

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Arrowhead Regional Medical Center | Conditions: Pterygium | Phase 4 | Status: COMPLETED